Metir (LSE:MET) said trading for the year ended 31 December 2025 was in line with management expectations, with revenues forecast to surge to around £1.5m from £0.23m in the prior year. The sharp increase was driven by strong overseas demand for its Microtox instruments and reagents, renewed uptake of its relaunched sulphate-reducing bacteria test kits, and progress on sizeable potable water monitoring projects, including a continuous toxic monitoring installation in Qatar.
The company noted that manufacturing constraints at outsourced suppliers during the fourth quarter restricted its ability to convert orders into revenue, resulting in some Microtox unit shipments being deferred into early 2026. Despite these short-term limitations, demand remained robust across key product lines. To address capacity bottlenecks and support future growth, Metir strengthened its balance sheet through a £1m fundraising, which will be used to expand production capability, increase exposure to higher-margin recurring reagent sales, and accelerate the development of new technologies.
Looking ahead, the group is advancing innovations such as mobile PFAS monitoring solutions and real-time pathogen detection platforms. The board believes these initiatives, combined with increased manufacturing capacity, will underpin near-term revenue growth, improve margins and move the business closer to sustainable profitability.
More about Metir plc
Metir plc is a UK-headquartered provider of rapid-response, mobile and point-of-use water and environmental monitoring technologies, operating through its Modern Water and Microsaic Systems divisions. The company develops and supplies instruments, reagents and testing kits for toxicity, PFAS monitoring and pathogen detection, delivering real-time water and liquid quality data for environmental, public health and industrial customers worldwide.
Leave a Reply